Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysisPuya Gharahkhani, Geoffrey Liu, Rebecca C. Fitzgerald et al.|The Lancet Oncology|2016Cited by 182
Genome‐wide association study identifies an early onset pancreatic cancer risk locusDaniele Campa, Rita T. Lawlor, Gabriele Capurso et al.|International Journal of Cancer|2020Cited by 33
In vitro study comparing the efficacy of the water-soluble HSP90 inhibitors, 17-AEPGA and 17-DMAG, with that of the non-water-soluble HSP90 inhibitor, 17-AAG, in breast cancer cell linesTarik Ghadban, Yogesh K. Vashist|International Journal of Molecular Medicine|2016Cited by 23
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer RiskYe Lu, Daniela Basso, Chiara Corradi et al.|Frontiers in Genetics|2021Cited by 20
Germline variation in the insulin-like growth factor pathway and risk of Barrett’s esophagus and esophageal adenocarcinomaShruti Dighe, Mario Anders, Jianhong Chen et al.|Carcinogenesis|2020Cited by 14